申请人:——
公开号:US05668162A1
公开(公告)日:1997-09-16
Plasma levels of Lp(a) are lowered by administering an isothiazolone having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het.
通过给予具有一般结构##STR1##的异噻唑酮,其中A是可能含有最多3个来自O、S和N的杂原子的单环或双环环;R.sup.1和R.sup.2是取代基,如烷基、烷氧基、羟基、硝基、氰基、氨基和羧基;而R.sup.5是烷基、环烷基、苯基和杂环基,可降低Lp(a)的血浆水平。